Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000929638-02-000118
Filing Date
2002-09-16
Accepted
2002-09-16 16:16:15
Documents
1
Group Members
BANCIRELAND/FIRST FINANCIAL, INC.BIAM (US) INC.COLE PARTNERS LLCDAVID L. COHENHAROLD J. LEVYIBI INTERFUNDINGIRIDIAN ASSET MANAGEMENT LLCIRIDIAN PRIVATE BUSINESS VALUE EQUITY FUND, L.P.THE GOVERNOR AND COMPANY OF THE BANK OF IRELAND

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D a1064320.txt SC 13D 52362
  Complete submission text file 0000929638-02-000118.txt   54759
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
ICN PHARMACEUTICALS INC (Subject) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44365 | Film No.: 02765014
SIC: 2834 Pharmaceutical Preparations

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST RD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

EIN.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231